Paper

Tree Display

AceDB Schema

XML Display

Feedback

Paper Report for: Bullock_2002_Int.J.Geriatr.Psychiatry_17_288

Reference

Title: Switching cholinesterase inhibitor therapy in Alzheimer's disease--donepezil to rivastigmine, is it worth it?
Bullock R, Connolly C
Ref: Int J Geriatr Psychiatry, 17:288, 2002 : PubMed

        



Related information



Citations formats

Bullock R, Connolly C (2002)
Switching cholinesterase inhibitor therapy in Alzheimer's disease--donepezil to rivastigmine, is it worth it?
Int J Geriatr Psychiatry 17: 288-9

Bullock R, Connolly C (2002)
Int J Geriatr Psychiatry 17: 288-9



Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer